Who
Knuettel Francis II
Director
Company insider
Files Form 4 as: Director, Beeline Holdings; Director, Splash Beverage Group, Inc. (NV); CFO, Treas & Secty, Pelthos Therapeutics; Director, Forum Markets; CEO and President, Unrivaled Brands; Director, SCWorx; Chief Financial Officer, Aqua Metals; Director, Spindle.
In numbers
- Trades disclosed
- 67
- Buys
- 7
- Sells
- 1
- Bought
- $40K
- Sold
- $81K
- Companies
- 10
- Companies where not an officer
- 6
- First trade
- 25 Apr 2008
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | BLNE Beeline HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | BLNE Beeline HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | Splash Beverage Group, Inc. (NV)option or derivative · Beverages | SEC FORM 4 Code A | —500,000 | filing |
| 8 Jun 2026filed 10 Jun 2026 | Splash Beverage Group, Inc. (NV)option or derivative · Beverages | SEC FORM 4 Code A | —500,000 | filing |
| 28 May 2026filed 1 Jun 2026 | BLNE Beeline HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | BLNE Beeline HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code D | —13,947 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $40K1,500 at $26.84 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —59,500 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —59,500 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —42,500 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —42,500 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code D | —13,947 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $40K1,500 at $26.84 | filing |
| 16 Dec 2025filed 17 Dec 2025 | BLNE Beeline HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 2 Oct 2025filed 6 Oct 2025 | BLNE Beeline HoldingsConsumer & Specialty Finance | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 2 Jul 2025filed 1 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —33,472 at $0.00 | filing |
| 2 Jul 2025filed 1 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —33,472 at $0.00 | filing |
| 2 Jul 2025filed 7 Jul 2025 | PTHS Pelthos Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —33,472 | filing |
| 2 Jul 2025filed 7 Jul 2025 | PTHS Pelthos Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —102,000 | filing |
News
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Downgraded by Zacks Research to Strong SellPTHS · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Knuettel Francis II; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.